The study will gather information to assist Empatica’s wearable device in detecting a type of seizure that impact individuals when prescription drugs lose their effectiveness.
Empatica, a wearable technology company, has revealed that it is working on a medical study to create a computer program that can anticipate refractory seizures.
The trial, set to recruit participants in early 2024, will focus on gathering medical information to develop a computer program that can identify personalized periods of seizure risk for patients with epilepsy.
Utilizing the Embrace smartwatch, the program is designed to predict refractory seizures in advance by analyzing biomarkers and changes in a patient’s day-to-day routine.
The leading body of Empatica, Rosalind Picard, commented, “We are excited to announce our plans to begin a large clinical study aimed at using wearable technology to enable reliable seizure forecasting.”
Picard continued by stating, “Patients with epilepsy understand the toll that uncertainty around seizures takes and we hope that this study will help give them better control over their life, reducing stress and perhaps also enabling early interventions that ultimately reduce or prevent seizures from happening.”
© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.